Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psychedelic Effects in Healthy Volunteers”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Very early researchWithdrawnNCT05252598
What this trial is testing

Mood and Cognitive Effects of Psilocybin in Healthy Participants

Who this might be right for
Mood DisturbanceMood ChangeSleep Disturbance+7 more
Optimi Health Corporation
Early research (Phase 1)Looking for participantsNCT06772753
What this trial is testing

Investigation of Psychedelic Effects in Psychoactive Substances

Who this might be right for
Psychedelic Effects in Healthy Volunteers
Johns Hopkins University 50
Early research (Phase 1)Study completedNCT05175430
What this trial is testing

Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects

Who this might be right for
Healthy
University Hospital, Basel, Switzerland 24
Testing effectiveness (Phase 2)Looking for participantsNCT06768944
What this trial is testing

Subjective Experience Following Psilocybin

Who this might be right for
Investigating the Importance of the Subjective Psychedelic Experience
University of Calgary 128
Early research (Phase 1)Study completedNCT05478278
What this trial is testing

An Evaluation of Psilocybin's Effect on Cardiac Repolarization and the Effect of Food on Psilocybin's Pharmacokinetics

Who this might be right for
QTc IntervalPharmacokinetics
Usona Institute 60
Testing effectiveness (Phase 2)Study completedNCT05385783
What this trial is testing

A Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Cybin IRL Limited 57
Not applicableNot Yet RecruitingNCT07661823
What this trial is testing

QAIAx (AIhealth4U) - AI Smart Health Cities: Microcity Enclave Program (Quantum AI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360)

Who this might be right for
Asperger's DisorderAsperger DisorderAutism Disorder+41 more
Veterans Recovery Network Inc. 1,000,000
Very early researchLooking for participantsNCT07565493
What this trial is testing

Psilocybin Administration With 5-HT1a Blockade

Who this might be right for
Psychedelic Effects in Healthy Volunteers
Johns Hopkins University 18
Early research (Phase 1)Study completedNCT05964647
What this trial is testing

Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects

Who this might be right for
Healthy
University Hospital, Basel, Switzerland 20
Not applicableUnknownNCT06529939
What this trial is testing

The Effects of Psilocybin on Shared Experience in Film Processing

Who this might be right for
Disorders of ConsciousnessPsychedelic Experiences
Western University, Canada 30
Early research (Phase 1)Looking for participantsNCT07444788
What this trial is testing

Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants

Who this might be right for
5-methoxy-dimethyltryptamine (5-MeO-DMT)
University Hospital, Basel, Switzerland 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05434156
What this trial is testing

ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression

Who this might be right for
Healthy VolunteersMajor Depressive DisorderDepression
Eleusis Therapeutics 84